| Dr Clay Earl Lyddane, MD PHD | |
|
3311 E Murdock St, Wichita, KS 67208-3054 | |
| (316) 689-9185 | |
| (316) 689-9909 |
| Full Name | Dr Clay Earl Lyddane |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 18 Years |
| Location | 3311 E Murdock St, Wichita, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760641476 | NPI | - | NPPES |
| 200740730A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 04-35145 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Via Christi Hospital-wichita | Wichita, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group Via Christi, Pa | 2961314497 | 177 |
News Archive
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.
A $634,000 grant from the Department of Defense is allowing researchers at the University at Buffalo to investigate a trio of environmental factors and their influence on the progression of multiple sclerosis.
Stress causes today more cases of prolonged absence from work due to sickness. Work and identity are more closely knit together than ever before, and therefore work becomes a matter of life and death to the person suffering from stress.
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
A new preprint released on the medRxiv* server by researchers at the University of Innsbruck, Austria, takes this further in order to establish the limits of storage procedures while working on viral surveillance in this area.
› Verified 7 days ago
| Entity Name | Ascension Medical Group Via Christi, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063453991 PECOS PAC ID: 2961314497 Enrollment ID: O20031104000089 |
News Archive
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.
A $634,000 grant from the Department of Defense is allowing researchers at the University at Buffalo to investigate a trio of environmental factors and their influence on the progression of multiple sclerosis.
Stress causes today more cases of prolonged absence from work due to sickness. Work and identity are more closely knit together than ever before, and therefore work becomes a matter of life and death to the person suffering from stress.
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
A new preprint released on the medRxiv* server by researchers at the University of Innsbruck, Austria, takes this further in order to establish the limits of storage procedures while working on viral surveillance in this area.
› Verified 7 days ago
| Entity Name | Kingman County Family Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770785362 PECOS PAC ID: 0941266852 Enrollment ID: O20041202000643 |
News Archive
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.
A $634,000 grant from the Department of Defense is allowing researchers at the University at Buffalo to investigate a trio of environmental factors and their influence on the progression of multiple sclerosis.
Stress causes today more cases of prolonged absence from work due to sickness. Work and identity are more closely knit together than ever before, and therefore work becomes a matter of life and death to the person suffering from stress.
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
A new preprint released on the medRxiv* server by researchers at the University of Innsbruck, Austria, takes this further in order to establish the limits of storage procedures while working on viral surveillance in this area.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clay Earl Lyddane, MD PHD 3311 E Murdock St, Wichita, KS 67208-3054 Ph: (316) 689-9185 | Dr Clay Earl Lyddane, MD PHD 3311 E Murdock St, Wichita, KS 67208-3054 Ph: (316) 689-9185 |
News Archive
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.
A $634,000 grant from the Department of Defense is allowing researchers at the University at Buffalo to investigate a trio of environmental factors and their influence on the progression of multiple sclerosis.
Stress causes today more cases of prolonged absence from work due to sickness. Work and identity are more closely knit together than ever before, and therefore work becomes a matter of life and death to the person suffering from stress.
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
A new preprint released on the medRxiv* server by researchers at the University of Innsbruck, Austria, takes this further in order to establish the limits of storage procedures while working on viral surveillance in this area.
› Verified 7 days ago
Dr. Oral E Bass, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2626 N Webb Rd, Wichita, KS 67226 Phone: 316-636-6100 Fax: 316-636-5813 | |
Dr. Christel Orphee Wambi- Kiesse, M.D. Urology Medicare: Medicare Enrolled Practice Location: 5500 E Kellogg Dr, Wichita, KS 67218 Phone: 316-685-2221 | |
Dr. George F Zakharia, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2626 N Webb Rd, Wichita, KS 67226 Phone: 316-636-6100 Fax: 316-636-5813 | |
William David Mcdonough, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 3311 E Murdock St, Wichita, KS 67208 Phone: 316-689-9234 Fax: 316-689-9909 | |
Rodney G Handsfield, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1130 S Clifton Ave, Wichita, KS 67218 Phone: 316-260-4000 Fax: 316-260-1500 | |
Surendra Kolla, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3311 E Murdock St, Wichita, KS 67208 Phone: 316-689-9185 | |
Gregory F Byrd, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2626 N Webb Rd, Wichita, KS 67226 Phone: 316-636-6100 Fax: 316-636-5813 |